跳至主要内容
临床试验/TCTR20191226002
TCTR20191226002已完成3 期

Does the presence of cirrhosis influence on the mortality rate in patients with acute-on-chronic liver failure? APASL-ACLF Research Consortium study.

one0 个研究点目标入组 1,621 人开始时间: 2019年12月26日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
one
入组人数
1,621

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • All adult patients, age above 18 years old, who were hospitalized from the emergency room or outpatient clinical due to having ACLF

排除标准

  • decompensated cirrhosis, concomitant malignancy, pregnancy, severe co-morbidities (such as severe neurological deficit, poor cardiac function, chronic lung disease that limits activity in daily life, uncontrolled autoimmune diseases, etc.), chronic kidney disease and currently receive immunosuppressant

研究者

发起方
one

相似试验